Roivant Sciences Ltd. (ROIV)
Roivant Sciences Market Cap : 19.15B for Feb. 12, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Immunovant, Inc. | 5.219B |
| GSK Plc | 117.47B |
| Kiniksa Pharmaceuticals International Plc | 3.389B |
| Silence Therapeutics Plc | 226.72M |
| Adaptimmune Therapeutics Plc | 7.952M |
Market Cap Related Metrics
| PS Ratio | 1389.45 |
| PEG Ratio | -0.0324 |
| Price to Book Value | 4.484 |
| Price | 26.75 |
| Earnings Yield | -4.37% |
| PEGY Ratio | -0.0324 |